Molecular Glues and Data Mining Revolutionize Oncology Drug Development
Recent research has expanded the understanding of molecular glue degraders, revealing that they can target a much wider array of proteins than previously thought, including those with surface features beyond the beta-hairpin loop motif, opening new possibilities for drug development against previously 'untouchable' proteins.